Trump’s $1.5 Trillion AI Mandate Transcript [June Webinar]

So to be clear: The profit potential here is off the charts.

And I’ve spotted three tiny stocks I expect to explode once this AI mandate comes into effect.

One of them is trading for under $5 right now…

It’s backed by NVIDIA – they just made their largest ever external investment in this tiny firm...

But there’s not much time left to get in before prices take off.

I’ll give you all the facts…

Plus I’ll share my top recommendations – which are perfectly positioned to see huge gains once this AI mandate takes effect.

But before we get into all that… there’s one problem.

It’s a big problem.

So I want to address it right away.

Instead, it will affect a sector that’s HATED by the mainstream media.

And look, I’m very hesitant to guarantee anything… but I guarantee you this:

When I reveal this sector, there will be folks in the audience who will think I lost my marbles.

There will be viewers who think I should be hauled out of here in a straight jacket.

Now, why am I saying that?

Simple, because I’ve been through this before, Charles…

Several times actually.

People thought I’d lost my mind when I predicted the 2008 crisis over a year in advance…

Including the best performing stock of 2025 – which soared 16,800%.

And that’s nothing compared to what I expect to see in this sector soon..

Trump’s AI Mandate could take effect just days from now…

It’s already passed the senate…

And in just a few days it could force every single U.S. biotech firm to integrate AI into their business operations – BY LAW.

Now, in case you’re wondering…

Isn’t biotech way too risky?

Hasn’t this sector been getting hammered under Trump?

See, here’s the thing…

Take Bright Mind Biosciences for example.

It’s a tiny AI firm that’s been described as a “cutting-edge biotech company”...

They’re currently doing a Phase 1 study on a new brain drug they’re trying to bring to market.

And this is why Trump’s AI Mandate will be such a big deal…

Charles, usually these guys would give a new treatment to a bunch of test subjects and ask them “does it make you feel weird? Are there any side effects?”.

That’s how these tests were done before AI came around.

It’s not exactly scientific.

But look at what Bright Mind Bio is doing instead.

They’re using an AI tool called Brain Network Analytics…

That’s a 20X return in four months!

It’s incredible.

And all these examples I showed you – these are biotech firms that are choosing to use AI.

Once Trump’s AI mandate kicks in – it will no longer be a choice.

They will have to use AI, or they will go out of business.

Think about that…

Just days from now… all 6,653 biotech firms in the United States could be forced to integrate AI into their process.

And when that happens, the biggest winners won’t be the biotech firms that use AI (although they can hand investors incredible returns)...

No.

The biggest winners will be tiny firms supplying the critical AI software…

The infrastructure, the platforms all these 6,653 firms desperately need.

Usually, genetic tests are slow… they’re done by hand… they’re prone to error…

It can take up to 8 weeks to get your test results.

But GeneDx’s AI tool can scan 750,000+ genomes and millions of data points…

Instead of weeks, this AI tool spits out genetic test results in just 48 hours!

This single AI breakthrough could save countless lives going forward…

And GeneDx isn’t just using this AI tool for themselves.

Just like Amazon is renting out cloud computing power to AI companies…

GeneDx is renting out their AI tool to other biotech firms…

And just like Amazon – GeneDx was a goldmine for investors.

Shares have exploded 2,700% in the past year alone…

And on the other hand, it’s gonna drive a LOT of business for AI software providers like GeneDx.

I mean think about it...

Just days from now, thousands of US biotech firms could be forced to use AI software in their drug discovery process…

So what are they gonna do?

Spend years and millions of dollars building it themselves?

No, a lot of them will use AI technology that already exists.

And the firms that provide that, like GeneDx, will do incredibly well.

Now, to be clear – please don’t run out and buy GeneDx. It has already taken off.

But I’ve discovered another tiny stock that provides AI software to pharma giants like Eli Lilly, Novartis and more…

They provide the AI tools to develop new drugs – and they get a cut of all the sales they help generate.

And just like GeneDx which I mentioned earlier… and which soared over 9,000% this year…

This tiny, NVIDIA-backed firm is building AI tools that I expect will benefit massively from Trump’s AI mandate…

Right now, shares are trading for under $5.

But I don’t expect prices to stay this cheap for long.

Because you have to ask yourself this…

Why would NVIDIA go all in on this specific biotech firm…

At this specific point in time.

Well, I believe they’re seeing the same opportunity I’m seeing…

That is HUGE.

Just think about what that means…

Going forward, all 6,653 biotech firms on U.S. soil will have to replace animal testing with AI-based computational models.

If they don’t do that – they won’t be able to get drugs approved.

Are you starting to see why I’m pounding the table on this?

It’s the first time in human history that a President MANDATES an entire industry to use AI in their business operations.

The FDA says it’s a “historic first for the agency”... and a “game changer”...

But how many investors will miss out?

Simply because they listen to the mainstream media… they listen to the “experts”... and they’ve been PROGRAMMED to avoid biotech.

This is Wall Street’s brainwashing in action.

Frankly, it makes me sick.

Mom and pop investors are being scared away from the biggest biotech opportunity I've seen in over three decades.

And that’s why I’m pounding the table today for folks to get in on this.

Mark my words, if you fall for the mainstream media’s lies – you will miss out on the profit opportunity of a lifetime.

So how can you get in on this?

Simple.

Sounds crazy, right?

But that’s exactly what my first AI biotech recommendation brings to the table…

While everyone’s chasing the next hot drug…

This under-the-radar company is selling the picks and shovels for this AI biotech boom.

They’ve built a cutting-edge AI-powered drug discovery platform…

It’s so advanced, it can simulate millions of compounds before a single test tube is touched.

NVIDIA’s head of healthcare calls it the “world-leading physics-based platform” which has “spearheaded the last two decades of computational drug and materials discovery.”

And I think that’s putting it lightly.

Shares are dirt cheap – you can get in for just $20 right now.

But I don’t expect prices to stay that low for long.

Remember, this single stock could hand investors AI Biotech Royalties for life…

From every drug that’s ever made using their AI software.

And Wall Street is starting to wake up to that fact.

Big institutional buyers like BlackRock… Vanguard Group… and the Bill & Melinda Gates foundation are gobbling up shares as we speak.

I highly recommend taking a position in this firm right away.

And I’ll tell you exactly how to do that in just a second…

But first, there’s another AI biotech stock that is a screaming buy right now.

And this tiny firm wants to do the same – they’re aiming to provide the AI infrastructure for biotech drug development.

They’re building an AI supercomputer that can compress 5-7 years of drug development into just months…

And their AI tech is so advanced, they received backing from NVIDIA.

Now, Charles, here's the thing…

NVIDIA is backing over 80 different startups – they’ve invested over $1 billion last year alone…

But – and I’ve mentioned this before – they’ve just made their biggest ever external investment EVER in this tiny firm…

So this AI Biotech moonshot – it’s incredibly time-sensitive.

See, I have 21 different biotech firms on my watch list right now…

But these three… the two AI infrastructure plays and the AI biotech moonshot… these are the most urgent – and the most potentially lucrative.

They all have strong catalysts coming up…

And of course, there’s Trump’s AI Mandate – which could take effect just days from now…

When that happens, I predict it’ll send shockwaves through the biotech sector.

And I expect these three AI biotech plays to do very, very well.

So here’s what I recommend:

You’ll find all the information you need to get started – the names, ticker symbols, an in-depth analysis – in this special report.

And I’d like to rush everyone in the audience a copy immediately.

It could be in your inbox just minutes from now.

All I’m asking in return?

Try out my exclusive Biotech research service, Biotech Insider…

And I’ll send you a copy of this report as a personal welcome gift right away.

Biotech Insider is my VIP research service, focused on explosive opportunities in the biotech sector…

That’s including all winners and losers.

And what’s exciting about Biotech Insider is… there’s a lot of action, it’s a very active service.

Usually, we’re in and out of these biotech trades in 12-18 months.

But in some cases… like when a biotech firm releases outstanding clinical study results or gets acquired by a competitor…

In those cases the gains can come FAST.

Like Array Bio for example, which was acquired by Pfizer a while back.

Everyone who followed my recommendation had a chance to lock in 148% gains in one morning!

And to be clear… Biotech Insider is by no means cheap.

That’s by design.

Remember, Dylan is a former Wall Street insider with a 34-year track record of picking biotech winners before they break out.

That’s why the cost for one year of Biotech Insider is $2,997.

However, because we’re looking at a historic opportunity here – Trump’s AI Mandate for biotech – you’re not going to be paying anywhere near the retail price.

Dylan has agreed to a special discount ONLY for attendees of this LIVE event.

In short: You’re not going to pay anywhere near the $2,997 fee.

Today, you can lock in a full year of membership for only $1,997 – a full $1,000 OFF the retail price.

Of course, if you’re sitting at home, and the cost of this service could be a risk financially…

Then let me tell you…

I never ever want to be the cause of any financial strain to anyone.

So if buying Biotech Insider represents a terrific burden, don’t do it.

But I know for a lot of folks watching right now, $1,997 is certainly an investment, but it’s not going to break the bank.

So relative to what we bring to the table – in my opinion, it’s a no-brainer.

The track record we have speaks for itself.

And frankly, I don’t know anywhere in the world where you can get access to this level of research, for such a small amount of money.

There are professional research houses that sell to Wall Street, and their research services start at $2 million a year.

You just can’t get access to this quality of research, anywhere, for even a fraction of this cost.

So again: If this represents an extreme financial hardship, wait.

Build up your cash to the point where you can come work with me in the future, when it makes more sense for you.

However, if this is not a financial hardship for you, then I think it is a no-brainer right?

When you have an opportunity like this… to get ahead of a once-in-a-decade regulatory shift…

When you can have the ability to take a small amount of money and move the needle on your net worth, without putting your current lifestyle at risk… you’ve got to pull the trigger.

Especially when we’re talking about firms backed by NVIDIA… Bayer… BlackRock…

I mean we’re talking about some of the smartest investors on the planet here who are piling into these AI biotech firms.

And this is a rare opportunity to position yourself for what the FDA calls a “historic first” in their agency’s history.

Again...

And with my recommendations, I believe you’re in the perfect position to take advantage.

Just remember, the clock is ticking…

Trump’s AI Mandate has already passed the senate…

It could go into effect just days from now… as early as June 27th.

So there’s not much time left to take advantage.

I believe Biotech Insider is your first-class ticket to achieve real financial freedom.

Each of my top AI biotech plays could hand you windfall gains over the next 12 months.

So I urge you: Click the button right now.

Q1: Is there any kind of guarantee?

Yes.

As always, customers are covered by our 30-day money-back guarantee.

Meaning, you have 30 days to try out Biotech Insider at your leisure.

If you’re not 100% satisfied, reach out to our customer support team and they’ll issue you a full refund of your membership fee.

Now, with that said, I’m sure you’ll be delighted with your membership.

Because with Biotech Insider we focus on explosive biotech stocks that are ready for big breakouts.

And as I mentioned before, we’ve done very well.

Our average, average gain since 2018 is 48% per trade. That’s including all winners and losers.

So this is about more than just giving you a couple of “hot” stocks...

Biotech Insider is giving you access to an entire pipeline of explosive opportunities…

We’re talking about at least 12 recommendations per year – each with the potential to turn a small stake into a retirement windfall.

That’s why we're looking for serious investors committed to their families' financial future.

Not tire kickers looking to make a quick buck on a single stock pick who will never seriously make the changes they need to make to succeed.

Of course, as we always say, we're not hostage takers.

If you can't stick with us for one reason or another, we're not going to force you to keep getting our monthly alerts.

Q2: How much could investors realistically make on these AI biotech stocks?

That’s a great question.

And look, a lot of newsletter publishers out there LOVE to make overhyped profit claims to sell their products.

But here at Behind the Markets, we like to stick to the facts.

And the reality is… biotech can be very, very lucrative.

We’ve mentioned this before…

Seven out of the twenty best performing stocks this year are biotech stocks.

We’re talking about gains as high as 942% on The Oncology Institute…

1,677% on Kindly MD…

Regencell was the best-performing stock of the entire year, by the way.

So that’s the profit potential you’re looking at with biotech – under normal circumstances.

And we’re looking at a historic, once-in-a-decade regulatory shift here – Trump’s coming AI Mandate.

Now remember, I have identified two AI stocks that will provide the infrastructure for this mandate…

That means 6,653 U.S. biotech firms could soon be forced to use the type of technology these firms have already perfected.

Plus my biotech moonshot…

A tiny firm that’s using AI to dethrone the world’s most lucrative drug – with a product that’s shown to be 50% more effective in clinical studies.

So I want to make myself very clear here…

Q3: Why is the price of Biotech Insider so high?

To answer your question...

Let’s take a look at the ENTIRE track record we’ve delivered since Biotech Insider launched in 2018.

We’ve closed out a total of 50 biotech trades.

The average gain over ALL of those plays – winners and losers – is 48%.

Now to put that into context…

The S&P 500 returns an average of 10% per year, historically.

So we’ve been outperforming the market by almost 5X.

And it doesn’t stop there.

Let’s compare Biotech Insider to some of the best-performing hedge funds of all time.

Ray Dalio, for example, who runs Bridgewater Associates.

He averages 12% annually, that’s beating the S&P 500 by 20%. Not bad.

But we’ve been doing 4 times better than that.

Or Paul Tudor Jones, who runs Tudor Investment Corp.

He’s averaged 19% annually.

We’re beating that by about 2.5 times.

Or billionaire Steve Cohen, who runs SAC Capital.

He’s averaged 30% annually before he turned his hedge fund into a private family office.

We’re still beating that by 1.6 times.

And these hedge funds are not cheap.

They usually charge 2% of assets and then 20% of your profits.

So they take a little piece of your initial investment…

And come back to cut a HUMONGUOUS slice of your profits.

Now, I’m not knocking hedge funds or anyone who wants to use them…

But 20% is a HUGE cut of your money.

At Biotech Insider, we don’t do that.

There’s no management fees… no hidden charges…

You pay your membership fee once and you get to keep all the profits you make.

So click that button now.

And that’s what I love about biotech…

The right stock with a strong catalyst can send you outsized gains FAST.

And remember, all my top AI Biotech recommendations have strong catalysts coming up…

And of course there’s Trump’s AI Mandate, which I believe will send this entire sector soaring.

So here’s the bottom line…

You’ve seen all the facts for yourself…

You’ve seen how AI is transforming biotech… and handing investors the chance at outsized gains.

That’s why seven out of the twenty best performing stocks this year are biotech stocks!

You’ve seen how President Trump is quietly backing the world’s first-ever AI Mandate…

Which could soon force 6,653 U.S. biotech firms to adapt AI into their operations…

And you’ve seen how the mainstream media is trying to bury this story…

They’re too busy trashing Trump over his trade policy, inflation, the LA riots, you name it…

All while elite investors like Jeff Bezos, Peter Thiel, NVIDIA and more are getting in position to take advantage of this historic opportunity.

Now, I have a 34-year track record of picking winning biotech stocks.

And I have identified three tiny stocks he believes will do very well in the days and weeks going forward.

A tiny AI firm that’s building the world’s most advanced AI Supercomputer for drug discovery – with full backing by NVIDIA.

Another firm that’s building an AI platform for accelerated drug discovery – and gets a cut of the drug sales they help generate…

This firm could pay you biotech royalties for life.

And finally, my AI Biotech moonshot… an AI-powered firm that’s on track to dethrone the world’s most profitable drug with a breakthrough replacement.

I believe every single one of these stocks could turn a tiny stake into a retirement windfall…

Now it’s your move.

Simply click the button right now.

Thank you again for tuning in today.

Time’s one of the most valuable things we have, so thank you.

And before I have to wrap this up, let me just remind you of how historic this opportunity is.

We are here today to take advantage of the first EVER AI Mandate in human history.

That’s a big deal.

I believe in a few years we will look at Trump’s AI Mandate as a turning point…

That separates our economy into before-AI and after-AI…

And you have a chance to take advantage.

So go click that button now.